Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07110038 |
| Title | DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Universitätsklinikum Carl Gustav Carus | RECRUITING | Dresden | Germany | Details | ||
| University Medical Center of Johannes Gutenberg-University | RECRUITING | Mainz | Germany | Details | ||
| University Hospital Mannheim | RECRUITING | Mannheim | Germany | Details | ||
| Technical University of Munich, University Hospital Munich | RECRUITING | Munich | Germany | Details | ||
| Caritas St. Josef Medical Center | RECRUITING | Regensburg | Germany | Details | ||
| Rostock University Medical Center | RECRUITING | Rostock | Germany | Details | ||
| University Hospital Tübingen | RECRUITING | Tübingen | Germany | Details |